Company Profiles

driven by the PitchBook Platform

GlySure

GlySure
2003 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Series C LATEST DEAL TYPE
$13.6M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of blood glucose monitoring systems designed to improve patient outcomes. The company's blood glucose monitoring systems improve patient outcomes by delivering safe, accurate and easy-to-use continuous monitoring services, enabling clinicians with the real-time and trending data required to optimize glycemic control.

Website
Formerly Known As
Scisense
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Outcome Management (Healthcare)
Primary Office
  • Units 4-6 The Quadrant
  • Abingdon Science Park
  • Abingdon OX14 3YS
  • England

+44 01235 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GlySure’s full profile, request a free trial.

GlySure Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 28-Nov-2012 $13.6M 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 23-Nov-2009 00000 00000 000.00 Completed Startup
1. Early Stage VC (Series A) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

GlySure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B2 000,000 00.00 00.00 00 00.00 0.00
Series B1 0,000,000 00.00 00.00 00 00.00 00.000
Series A 2,940,000 $1.66 $1.66 1x $1.66 40.19%
To view this company’s complete Cap Table, request access »

GlySure Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Amadeus Capital Partners Venture Capital Minority 000 0000 000000 0
Angel CoFund Angel Group Minority 000 0000 000000 0
Chester Investments Other Minority 000 0000 000000 0
Delta Partners Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

GlySure Executive Team (12)

Name Title Board
Seat
Contact
Info
Sally Mahoney Director, Finance and Corporate Services
Paul Mather Director of Business Development Europe
Roger Pamment Director, Product Marketing
Jan Walters Director, Quality Assurance and Regulatory Affairs
Barry Crane Board Member & Chief Technical Officer

5 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

GlySure Board Members (8)

Name Representing Role Since Contact
Info
Anne Glover Amadeus Capital Partners Board Member 000 0000
Barry Crane GlySure Board Member & Chief Technical Officer 000 0000
Frank Kenny GlySure Board Member 000 0000
Joey Mason Delta Partners Board Member 000 0000
Patrick Paul Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »